DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY Canadian Trademark Information

On Tuesday, January 31, 2023, a canadian trademark registration was filed for DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY by NanoVation Therapeutics Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 2236396. The current status of this trademark filing is Filing date accorded. The DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY trademark is filed in the description of Lipids for use in the manufacture of pharmaceuticals for the treatment or prevention of diseases or for reducing symptoms associated with aging; nucleic acid, namely RNA and DNA, for use in the manufacture of pharmaceuticals for the treatment or prevention of diseases or for reducing symptoms associated with aging; proteins and peptides for use in the manufacture of pharmaceuticals for the treatment or prevention of diseases or for reducing symptoms associated with aging; chemical ingredients, namely small molecule drugs for use in the manufacture of pharmaceuticals for the treatment or prevention of diseases or for reducing symptoms associated with aging. , Lipid-based pharmaceuticals, namely lipid-based delivery vehicles for the diagnosis, treatment or prevention of diseases or for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases or for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of diseases or for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of diseases or for reducing symptoms associated with aging. , Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals. , Providing pharmaceutical, lipid, nucleic acid and drug review services; providing pharmaceutical information to others; providing formulation development services; provision of pharmaceutical formulation information; provision of lipid formulation information and services; provision of nucleic acid pharmaceutical information and services, namely RNA and DNA; provision of small molecule, protein, and peptide pharmaceutical information; providing pharmacological information and services for lipids, nucleic acids, small molecule drugs, proteins, and peptides; providing diagnostic information and services in relation to lipid formulations. .